{"transactions":[{"id":1079229,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"common shares","published_at":"2025-07-30T11:23:09.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":750,"price":0.91,"value":682.5,"ownership":{"direct":true},"balance_after":750,"source":{"system":"sec-edgar","filing":"0001348362-25-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000134836225000013/primary_doc.xml","form_type":"4"}},{"id":1145614,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2025-05-16T17:27:43.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":1.04,"exercise_date":"2025-05-15","expiration_date":"2030-05-15","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001348362-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000134836225000009/primary_doc.xml","form_type":"4"}},{"id":1444385,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"common shares","published_at":"2024-08-01T12:25:52.000Z","date":"2024-07-31","kind":"sale","planned":false,"acquired":false,"shares":2567,"price":4,"value":10268.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001855763-24-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576324000012/primary_doc.xml","form_type":"4"}},{"id":1516147,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2024-05-15T17:37:12.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60067,"derivative":{"exercise_price":1.15,"exercise_date":"2023-10-26","expiration_date":"2028-10-26","underlying":"Common Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001855763-24-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576324000011/primary_doc.xml","form_type":"4"}},{"id":1516146,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"common shares","published_at":"2024-05-15T17:37:12.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":1.15,"value":2875.0,"ownership":{"direct":true},"balance_after":2567,"source":{"system":"sec-edgar","filing":"0001855763-24-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576324000011/primary_doc.xml","form_type":"4"}},{"id":1520922,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2024-05-10T17:24:01.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62567,"derivative":{"exercise_price":2.36,"exercise_date":"2024-04-26","expiration_date":"2029-04-26","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001855763-24-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576324000010/primary_doc.xml","form_type":"4"}},{"id":1752524,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2023-11-01T13:45:34.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52567,"derivative":{"exercise_price":1.15,"exercise_date":"2023-10-26","expiration_date":"2028-10-26","underlying":"Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001855763-23-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576323000009/primary_doc.xml","form_type":"4"}},{"id":2172028,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2022-08-29T17:32:43.000Z","date":"2022-08-29","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40067,"derivative":{"exercise_price":2.91,"exercise_date":"2022-08-29","expiration_date":"2027-08-29","underlying":"Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001855763-22-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576322000010/primary_doc.xml","form_type":"4"}},{"id":2581957,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2021-09-02T13:04:43.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27567,"derivative":{"exercise_price":6.23,"exercise_date":"2021-09-01","expiration_date":"2026-09-01","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001855763-21-000022","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576321000022/primary_doc.xml","form_type":"4"}},{"id":2676007,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2021-06-09T11:15:13.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17567,"derivative":{"exercise_price":7.08,"exercise_date":"2021-06-08","expiration_date":"2026-06-08","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-21-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576321000010/primary_doc.xml","form_type":"4"}},{"id":2676006,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2021-06-09T11:07:14.000Z","date":"2021-05-07","kind":"other","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cancellation of Options"}],"balance_after":12567,"derivative":{"exercise_price":9.6,"exercise_date":"2020-04-23","expiration_date":"2025-04-23","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-21-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576321000009/primary_doc.xml","form_type":"4"}},{"id":2738685,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2021-04-27T16:31:47.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17567,"derivative":{"exercise_price":5.31,"exercise_date":"2021-04-26","expiration_date":"2026-04-26","underlying":"Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001855763-21-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576321000003/primary_doc.xml","form_type":"4"}}]}